ELDN Eledon Pharmaceuticals
- 1.860
- -0.130-6.53%
- 1.950
- +0.090+4.85%
Eledon Pharmaceuticals News
Eledon Pharmaceuticals | 10-K: Annual report
Eledon Pharmaceuticals | 8-K: Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Eledon Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Eledon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%), etc.
Eledon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(17.9%),BVF Inc.(17.9%), etc.
Eledon Pharmaceuticals: Q3 2023 Earnings Report
Eledon Pharmaceuticals | 8-K: Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Eledon Pharmaceuticals | 8-K: Current report
Eledon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Robinson James A. Jr.
Eledon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kirk Allan
Eledon Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Robinson James A. Jr.
Eledon Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Kirk Allan
Eledon Pharmaceuticals | 8-K: Current report
Eledon Pharmaceuticals | 8-K: Current report
Eledon Pharmaceuticals | 8-K: Current report
Eledon Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Eledon Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
Eledon Pharmaceuticals | 8-K: Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results
Eledon Pharmaceuticals | 8-K: Current report
Eledon Pharmaceuticals | 424B3: Prospectus
Analysis
Price Target
No Data
